Conning Inc’s Bio-Techne TECH Stock Holding History

Conning Inc’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,892	Closed	-$205K	–	424
2022 Q1	$205K	Buy	+1,892	New	+$195K	0.01%	417
2016 Q1	–	Sell	-12,720	Closed	-$286K	–	574
2015 Q4	$286K	Buy	+12,720	New	+$290K	0.01%	476

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Conning Inc's TECH Position: Q2 2022 in Review

Conning Inc sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 1,892 shares — an estimated $205K sold.

Conning Inc first reported a position in TECH in Q4 2015 and held it in 2 quarters. The position peaked at $286K in Q4 2015. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Conning Inc reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
Conning Inc sold 1,892 Bio-Techne shares in Q2 2022, an estimated $205K.
Conning Inc first reported a position in Bio-Techne in Q4 2015 and held it in 2 quarters.
Conning Inc's Bio-Techne position peaked at $286K in Q4 2015.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Conning Inc's 13F filing for Q2 2022, filed 20 Jul 2022.